# VTVT (vTv Therapeutics Inc.) - SEC EDGAR Financial Statements

> vTv Therapeutics Inc. reported $36.84M in revenue and a net loss of $7.68M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a -29.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/VTVT
- Markdown: https://convexityos.com/fundamentals/VTVT.md
- SEC CIK: 0001641489
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:50 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001641489&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $36.84M | -100.0% YoY |
| Operating Income | TTM | -$10.98M | -29.8% margin |
| Net Income | TTM | -$7.68M | -20.8% net margin |
| Diluted EPS | TTM | -- | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $77.16M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $1.02M | $0 | $2.02M | $4.00M | $6.41M | $2.76M | $12.43M | $291K | $634K |
| Research & Development | $17.86M | $11.55M | $13.60M | $12.36M | $13.32M | $11.02M | $15.12M | $23.04M | $39.64M | $44.95M |
| Total Operating Expenses | $32.81M | $25.20M | $25.50M | $24.56M | $25.67M | $18.27M | $23.66M | $32.26M | $50.97M | $55.65M |
| **Operating Income** | -$32.81M | -$24.18M | -$25.50M | -$22.54M | -$21.66M | -$11.85M | -$20.89M | -$19.82M | -$50.68M | -$55.02M |
| **EBITDA** | -$32.79M | -$24.09M | -$25.41M | -$22.45M | -$21.57M | -$11.76M | -$20.85M | -$19.61M | -$50.48M | -$54.76M |
| Interest Income | $1.87M | $1.56M | $472K | $352K | $1.0K | $12K | $53K | $61K | $117K | $87K |
| Interest Expense | -- | $0 | $13K | $15K | $12K | $692K | $1.83M | $3.29M | $3.09M | $398K |
| Income Before Tax | -$31.08M | -$22.61M | -$25.97M | -$24.87M | -$17.62M | -$12.80M | -$21.84M | -$23.64M | -$53.85M | -$55.35M |
| Income Tax Expense | $0 | $100K | $0 | $200K | $115K | $0 | $100K | $200K | $800K | $0 |
| **Net Income** | -$26.97M | -$18.46M | -$20.25M | -$19.16M | -$12.99M | -$8.50M | -$13.04M | -$7.91M | -$16.14M | -$16.35M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $36.84M | $0 | $0 | $0 | $0 | $17K |
| Research & Development | $7.53M | $8.77M | $8.98M | $3.91M | $7.02M | $4.10M | $2.83M | $2.23M |
| Total Operating Expenses | $12.43M | $13.93M | $13.58M | $7.88M | $10.70M | $7.72M | $6.50M | $4.91M |
| **Operating Income** | -$12.43M | -$13.93M | $23.26M | -$7.88M | -$10.70M | -$7.72M | -$6.50M | -$4.89M |
| **EBITDA** | -$12.43M | -$13.93M | $23.26M | -$7.88M | -$10.70M | -$7.72M | -$6.49M | -$4.87M |
| Interest Income | $734K | $812K | $838K | $865K | $399K | $275K | $331K | $429K |
| Income Before Tax | -$11.62M | -$13.05M | $24.13M | -$7.14M | -$10.35M | -$7.38M | -$6.22M | -$4.44M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$11.62M | -$13.05M | $24.13M | -$7.14M | -$8.70M | -$6.05M | -$5.09M | -$3.63M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $88.93M | $36.75M | $9.45M | $12.13M | $13.41M | $5.75M | $1.78M | $1.68M | $11.76M | $51.51M |
| **Cash & Short-Term Investments** | $88.93M | $36.75M | $9.45M | $12.13M | $13.41M | $5.75M | $1.78M | $1.68M | $11.76M | $51.51M |
| Accounts Receivable, Net | -- | $62K | $102K | $173K | $57K | $158K | $5.0K | $0 | $8.00M | $0 |
| Other Current Assets | $218K | $175K | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $89.89M | $38.11M | $10.66M | $27.09M | $15.62M | $7.21M | $2.84M | $3.47M | $20.36M | $52.12M |
| Property, Plant & Equipment, Net | -- | $28K | $117K | $207K | $278K | $367K | $461K | $70K | $283K | $444K |
| Long-Term Investments | -- | -- | $0 | $5.59M | $9.17M | $6.72M | $2.48M | $2.48M | $2.48M | -- |
| Other Non-Current Assets | $6.0K | $153K | -- | -- | -- | -- | -- | -- | -- | $1.93M |
| **Total Non-Current Assets** | $6.0K | $153K | $361K | $6.14M | $9.85M | $7.57M | $6.43M | $5.09M | $7.55M | $2.38M |
| **Total Assets** | $89.90M | $38.27M | $11.02M | $33.24M | $25.47M | $14.79M | $9.27M | $8.56M | $27.92M | $54.49M |
| Accounts Payable | $1.13M | $939K | $4.08M | $2.46M | $1.88M | $1.93M | $2.23M | $2.90M | $2.27M | $3.06M |
| Short-Term Debt | -- | -- | -- | -- | $256K | $84K | $144K | $216K | -- | -- |
| Deferred Revenue (Current) | -- | $0 | $17K | $17K | $35K | $31K | $31K | $1.75M | $8.76M | $21K |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | -- | -- | -- | $433K |
| **Total Current Liabilities** | $6.64M | $5.20M | $10.62M | $7.71M | $8.50M | $6.39M | $13.38M | $18.84M | $26.93M | $11.43M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | -- | -- | $11.06M |
| Deferred Revenue (Non-Current) | $18.67M | $18.67M | $18.67M | $18.67M | $0 | $1.01M | $1.03M | $1.07M | $4.50M | -- |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | $50K | $260K | $260K | $290K | $433K |
| **Total Non-Current Liabilities** | $18.82M | $18.77M | $18.95M | $19.69M | $1.75M | $4.61M | $4.72M | $10.09M | $20.59M | $11.49M |
| **Total Liabilities** | $25.46M | $23.96M | $29.57M | $27.40M | $10.25M | $11.00M | $18.11M | $28.93M | $47.52M | $22.93M |
| **Total Debt (incl. Leases)** | -- | $169K | $338K | $492K | $932K | $915K | $1.08M | $216K | -- | $11.06M |
| Retained Earnings | -$326.7M | -$299.7M | -$281.0M | -$265.5M | -$248.8M | -$290.0M | -$233.5M | -$233.9M | -$279.1M | -$215.5M |
| **Total Stockholders' Equity** | $64.44M | $12.20M | -$24.68M | -$10.74M | -$9.74M | -$80.10M | -$49.02M | -$82.85M | -$151.0M | -$90.94M |
| Total Equity | $64.44M | $14.30M | -$24.68M | -$10.74M | -$9.74M | -$80.10M | -$49.02M | -$82.85M | -$151.0M | -$90.94M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $77.16M | $86.64M | $98.09M | $88.93M | $98.50M | $25.92M | $31.06M | $36.75M |
| **Cash & Short-Term Investments** | $77.16M | $86.64M | $98.09M | $88.93M | $98.50M | $25.92M | $31.06M | $36.75M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | $62K |
| Other Current Assets | -- | $530K | $201K | $218K | $112K | $93K | $115K | $175K |
| **Total Current Assets** | $78.60M | $87.59M | $98.81M | $89.89M | $99.46M | $26.37M | $31.92M | $38.11M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | $14K | $16K | $19K | $28K |
| Other Non-Current Assets | $3.0K | $4.0K | $5.0K | $6.0K | -- | -- | -- | $153K |
| **Total Non-Current Assets** | $3.0K | $4.0K | $5.0K | $6.0K | $38K | $74K | $111K | $153K |
| **Total Assets** | $78.61M | $87.59M | $98.81M | $89.90M | $99.49M | $26.45M | $32.03M | $38.27M |
| Accounts Payable | -- | -- | -- | $1.13M | -- | -- | -- | $939K |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Current Liabilities** | $7.02M | $7.02M | $6.88M | $6.64M | $10.16M | $5.29M | $4.32M | $5.20M |
| Deferred Revenue (Non-Current) | $1.83M | $1.83M | $1.83M | $18.67M | $18.67M | $18.67M | $18.67M | $18.67M |
| **Total Non-Current Liabilities** | $1.90M | $1.94M | $1.97M | $18.82M | $18.79M | $18.75M | $18.81M | $18.77M |
| **Total Liabilities** | $8.92M | $8.96M | $8.85M | $25.46M | $28.95M | $24.04M | $23.13M | $23.96M |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | $32K | $79K | $125K | $169K |
| Retained Earnings | -$327.2M | -$315.6M | -$302.6M | -$326.7M | -$319.6M | -$310.9M | -$304.8M | -$299.7M |
| **Total Stockholders' Equity** | $69.69M | $78.63M | $89.96M | $64.44M | $70.54M | $2.76M | $7.92M | $12.20M |
| Total Equity | $69.69M | $78.63M | $89.96M | $64.44M | $70.54M | $2.40M | $8.90M | $14.30M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$31.08M | -$22.70M | -$25.97M | -$25.07M | -$17.73M | -$12.80M | -$21.94M | -$23.84M | -$54.65M | -$55.35M |
| Depreciation & Amortization | $16K | $89K | $90K | $92K | $89K | $94K | $39K | $218K | $197K | $265K |
| Stock-Based Compensation | $3.77M | $2.76M | $1.58M | $1.27M | $2.36M | $1.01M | $1.52M | $2.68M | $3.65M | $2.64M |
| Change in Receivables | -- | $40K | $71K | -$116K | $101K | -$153K | -$5.0K | $8.00M | -$8.00M | $69K |
| **Operating Cash Flow** | -$25.25M | -$25.31M | -$19.08M | -$16.02M | -$19.31M | -$18.00M | -$23.02M | -$26.86M | -$44.56M | -$48.21M |
| Capital Expenditure | -- | $0 | $0 | -$21K | $0 | $0 | -$70K | -$5.0K | -$57K | -$87K |
| **Free Cash Flow** | -- | -$25.31M | -$19.08M | -$16.04M | -$19.31M | -$18.00M | -$23.09M | -$26.86M | -$44.62M | -$48.30M |
| **Investing Cash Flow** | $0 | $0 | $4.40M | -$21K | $0 | $0 | $242K | $7.0K | -$25K | -$83K |
| Common Stock Issued | $0 | $2.46M | $0 | $0 | $26.76M | $14.43M | $5.44M | $21.50M | -- | -- |
| **Financing Cash Flow** | $77.44M | $52.61M | $12.00M | $14.75M | $26.98M | $19.47M | $22.87M | $16.61M | $7.50M | $11.79M |
| **Net Change in Cash** | $52.19M | $27.30M | -$2.68M | -$1.29M | $7.67M | $1.47M | $94K | -$10.24M | -$37.09M | -$36.50M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$11.62M | -$13.05M | $24.13M | -$7.14M | -$10.35M | -$7.38M | -$6.22M | -$4.44M |
| Depreciation & Amortization | $1.0K | $1.0K | $1.0K | $2.0K | $2.0K | $3.0K | $9.0K | $22K |
| Stock-Based Compensation | $1.97M | $1.73M | $1.39M | $1.02M | $1.01M | $930K | $813K | $825K |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | $180K |
| **Operating Cash Flow** | -$10.19M | -$11.44M | $9.15M | -$9.25M | -$5.22M | -$5.09M | -$5.69M | -$4.83M |
| **Financing Cash Flow** | -- | -- | -- | -$321K | $77.80M | -$42K | $0 | $0 |
| **Net Change in Cash** | -$9.48M | -$11.44M | $9.15M | -$9.57M | $72.58M | -$5.14M | -$5.69M | -$4.83M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -2377.6% | -- | -1116.9% | -540.9% | -184.8% | -755.9% | -159.4% | -17416.5% | -8678.2% |
| **Net Profit Margin** | -- | -1815.3% | -- | -949.7% | -324.3% | -132.5% | -471.9% | -63.6% | -5547.8% | -2579.2% |
| Return on Equity (ROE) | -41.9% | -151.3% | -- | -- | -- | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -30.0% | -48.2% | -183.8% | -57.7% | -51.0% | -57.5% | -140.8% | -92.4% | -57.8% | -30.0% |
| Current Ratio | 13.54x | 7.34x | 1.00x | 3.52x | 1.84x | 1.13x | 0.21x | 0.18x | 0.76x | 4.56x |
| Quick Ratio | 13.39x | 7.08x | 0.90x | 1.60x | 1.59x | 0.92x | 0.13x | 0.09x | 0.73x | 4.50x |
| Debt to Equity | -- | 0.01x | -- | -- | -- | -- | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | -100.0% | -- | -100.0% | -49.6% | -37.6% | +132.1% | -77.8% | +4172.9% | -54.1% | +22.2% |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -29.8% | -25.1% | -8.3% | -- | -175382.4% | -150717.6% | -147388.2% | -2377.6% |
| **Net Profit Margin** | -20.8% | -12.9% | 6.1% | -- | -138058.8% | -115029.4% | -109935.3% | -1815.3% |
| Return on Equity (ROE) | -11.0% | -6.0% | 2.5% | -41.9% | -33.3% | -708.0% | -236.0% | -151.3% |
| Return on Assets (ROA) | -9.8% | -5.4% | 2.3% | -30.0% | -23.6% | -73.9% | -58.4% | -48.2% |
| Current Ratio | 11.19x | 12.48x | 14.36x | 13.54x | 9.79x | 4.98x | 7.39x | 7.34x |
| Quick Ratio | 10.99x | 12.35x | 14.25x | 13.39x | 9.69x | 4.90x | 7.20x | 7.08x |
| Debt to Equity | -- | -- | -- | -- | 0.00x | 0.03x | 0.02x | 0.01x |
| **Revenue Growth (YoY)** | -- | -- | -- | -100.0% | -- | -- | -100.0% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
